Chapter title |
The Use of Somatic Hypermutation for the Affinity Maturation of Therapeutic Antibodies
|
---|---|
Chapter number | 24 |
Book title |
Antibody Engineering
|
Published in |
Methods in molecular biology, September 2018
|
DOI | 10.1007/978-1-4939-8648-4_24 |
Pubmed ID | |
Book ISBNs |
978-1-4939-8647-7, 978-1-4939-8648-4
|
Authors |
Peter M. Bowers, William J. Boyle, Robert Damoiseaux, Bowers, Peter M., Boyle, William J., Damoiseaux, Robert |
Abstract |
The engineering of antibodies and antibody fragments for affinity maturation, stability, and other biophysical characteristics is a common aspect of therapeutic development. Maturation of antibodies in B cells during the adaptive immune response is the result of a process called somatic hypermutation (SHM), in which the activation-induced cytidine deaminase (AID) acts to introduce mutations into immunoglobulin (Ig) genes. Iterative selection and clonal expansion of B cells containing affinity-enhancing mutations drive an increase in the overall affinity of antibodies. Here we describe the use of SHM coupled with mammalian cell surface display for the maturation of antibodies in vitro and the complementarity of these methods with the mining of immune lineages using next-generation sequencing (NGS). |
X Demographics
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 2 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 24 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 6 | 25% |
Researcher | 5 | 21% |
Professor > Associate Professor | 3 | 13% |
Other | 2 | 8% |
Student > Master | 2 | 8% |
Other | 2 | 8% |
Unknown | 4 | 17% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 7 | 29% |
Agricultural and Biological Sciences | 3 | 13% |
Immunology and Microbiology | 3 | 13% |
Engineering | 2 | 8% |
Unspecified | 1 | 4% |
Other | 3 | 13% |
Unknown | 5 | 21% |